NDC 80425-0180-01 - Amoxicillin and Clavulanate Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0180
- Requested NDC
- 80425-0180-01
- Package NDCs from labels
- 80425-0180-1, 80425-0180-2, 80425-0180-3, 80425-0180-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2025-02-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amoxicillin and Clavulanate Potassium - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2025-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0180-1 | Amoxicillin and Clavulanate Potassium | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 6 | |
| 80425-0180-2 | Amoxicillin and Clavulanate Potassium | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 6 | |
| 80425-0180-3 | Amoxicillin and Clavulanate Potassium | 14 in 1 BOTTLE | TABLET, FILM COATED | 14 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0180 | AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 6 | Current NDC, Legacy NDC, 3 package rows | 20250204_d294e4a2-8ce7-418d-e053-2a95a90ab10b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0180-1 | EA - Each | 80425-0180 | 444739e5-da19-41e1-8824-9f7dd13f80d4 | 1 | 2023-03-13 |
| 80425-0180-2 | EA - Each | 80425-0180 | d04fe114-f486-4525-b5ac-9899de674fcf | 1 | 2023-03-13 |
| 80425-0180-3 | EA - Each | 80425-0180 | bfa4e2cd-b009-4e92-9271-46e708d5316a | 1 | 2025-03-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals,Inc. | 76f315c4-acbc-76c1-e053-2a91aa0aebcd | 2024-06-12 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals,Inc. | 76ba0f8d-4d1c-a5ff-e053-2a91aa0a7555 | 2024-06-12 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals,Inc. | 6e9bf369-2f96-c7ae-e053-2a91aa0a715f | 2024-06-10 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals,Inc. | 7524da98-b0a5-3db8-e053-2a91aa0a6ff1 | 2024-06-10 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | 64a27ad7-4d32-69c8-e053-2a91aa0aa967 | 2024-06-06 | Warnings, Adverse reactions | 617296 Q42OMW3AT8 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | 6542fa18-6219-602f-e053-2991aa0a54d0 | 2024-06-06 | Warnings, Adverse reactions | 617296 Q42OMW3AT8 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | 6635fda2-15c3-2ff5-e053-2991aa0a5abb | 2024-06-06 | Warnings, Adverse reactions | 617296 Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | Aurobindo Pharma Limited | 234d0dfc-cb24-413f-b798-129c73eb848e | 2024-06-04 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Teva Pharmaceuticals USA, Inc. | 963e7bea-ff5d-420a-9cb2-e4aefb534b33 | 2024-06-01 | Warnings, Adverse reactions | 617296 562508 Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | Bryant Ranch Prepack | 7b182161-128e-430c-98b2-592c242ba711 | 2024-05-30 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Bryant Ranch Prepack | 260a3a79-9dd6-4c4b-82ec-f8050346e886 | 2024-05-30 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Bryant Ranch Prepack | aee851cf-428e-4d29-a281-078fe00c56b0 | 2024-05-30 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Bryant Ranch Prepack | 9925773d-8ea1-4193-91e3-52cc1ce5ca67 | 2024-05-30 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Bryant Ranch Prepack | 917a76e9-eb2b-4d49-9418-ff919a73cfad | 2024-05-29 | Warnings, Adverse reactions | 562508 Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Bryant Ranch Prepack | 71812ac4-9264-49f2-b9ab-ea1efd1af452 | 2024-05-29 | Warnings, Adverse reactions | 617296 Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | Teva Pharmaceuticals USA, Inc. | 4c0f348a-a65d-409c-8668-207c82a5e3cb | 2024-05-22 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | aaa35f65-cb9c-4b37-a126-c5ff2c2ef79d | 2024-05-16 | Warnings, Adverse reactions | 562508 Q42OMW3AT8 804826J2HU |
| Augmentin | AMOXICILLIN AND CLAVULANATE POTASSIUM | Allegis Holdings, LLC | 04a31a42-d79e-bbb4-e063-6394a90a63ee | 2024-05-16 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 2718248d-d948-466e-959b-1a972519f108 | 2024-05-14 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 14a5f8c2-fdaf-4ad4-982b-c5aa128e242d | 2024-05-06 | Warnings, Adverse reactions | 804826J2HU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.